Status:
COMPLETED
Validation of RespiLife for Detection of Respiratory Suppression
Lead Sponsor:
Bioresp Technologies, Inc.
Conditions:
Respiration Disorders
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the accuracy of RespiLife diagnostic technology for detection of respiratory rate and oxygen saturation in human subjects. This includes evaluation of Bioresp'...
Detailed Description
The purpose of this study is to evaluate the accuracy of RespiLife diagnostic technology for detection of respiratory rate and oxygen saturation in human subjects. This includes evaluation of Bioresp'...
Eligibility Criteria
Inclusion
- Able to understand and sign the informed consent
- English speaking.
- Able to comply with visits and follow ups included in this protocol
- Ages 18-80 years
Exclusion
- Mentally or cognitively incompetent persons who cannot understand the procedures or consent to the procedures.
- An unstable medical condition, acute of chronic, that in the opinion of the investigator puts the subject at health risks related this trial or interferes with the clinical trial and data collection.
- If a subject is not able to stop his CPAP or BiPAP therapy at least one week prior to the sleep study night. This will be determined ty the principal investigator based on her judgment.
- Skin rash on the forehead.
- A history of skin allergy to medical tape, even hypoallergenic tape.
- A history of skin cancer on the forehead.
Key Trial Info
Start Date :
December 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 20 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03819023
Start Date
December 20 2018
End Date
March 20 2019
Last Update
April 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peninsula Sleep Center
Burlingame, California, United States, 94010-3224